$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

$hdsn Overview Financials Valuation SEC Filings Company Website

2015 Q3 Form 10-Q Financial Statement

#000114420415064117 Filed on November 10, 2015

Income Statement

Concept	2015 Q3	2014 Q4	2014 Q3
Revenue	$21.68M	$8.060M	$15.30M
YoY Change	41.75%	67.22%	0.82%
Cost Of Revenue	$17.30M	$7.110M	$13.80M
YoY Change	25.34%	52.9%	5.48%
Gross Profit	$4.384M	$950.0K	$1.495M
YoY Change	193.24%	458.82%	-111.85%
Gross Profit Margin	20.22%	11.79%	9.77%
Selling, General & Admin	$2.482M	$2.930M	$1.622M
YoY Change	53.02%	22.59%	-11.51%
% of Gross Profit	56.61%	308.42%	108.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$540.0K	$350.0K	$220.0K
YoY Change	145.45%	66.67%	4.76%
% of Gross Profit	12.32%	36.84%	14.72%
Operating Expenses	$2.482M	$2.930M	$1.622M
YoY Change	53.02%	22.59%	-11.51%
Operating Profit	$1.902M	-$1.980M	-$127.0K
YoY Change	-1597.64%	-10.81%	-99.12%
Interest Expense	$157.0K	-$150.0K	$99.00K
YoY Change	58.59%	-40.0%	-59.92%
% of Operating Profit	8.25%
Other Income/Expense, Net	-$157.0K		-$99.00K
YoY Change	58.59%		-59.92%
Pretax Income	$1.745M	-$2.130M	-$226.0K
YoY Change	-872.12%	-13.41%	-98.46%
Income Tax	$663.0K	-$1.050M	-$118.0K
% Of Pretax Income	37.99%
Net Earnings	$1.082M	-$1.080M	-$108.0K
YoY Change	-1101.85%	-29.41%	-98.82%
Net Earnings / Revenue	4.99%	-13.4%	-0.71%
Basic Earnings Per Share	$0.03		$0.00
Diluted Earnings Per Share	$0.03	-$33.80K	$0.00
COMMON SHARES
Basic Shares Outstanding	32.64M shares	32.03M shares	32.03M shares
Diluted Shares Outstanding	33.86M shares		32.03M shares

Balance Sheet

Concept	2015 Q3	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.000M	$900.0K	$1.200M
YoY Change	-16.67%	28.57%	-69.23%
Cash & Equivalents	$1.040M	$935.0K	$1.173M
Short-Term Investments
Other Short-Term Assets	$5.900M	$1.400M	$5.000M
YoY Change	18.0%	75.0%	-5.66%
Inventory	$48.96M	$37.02M	$27.65M
Prepaid Expenses
Receivables	$9.614M	$3.968M	$9.036M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$65.50M	$43.33M	$42.91M
YoY Change	52.65%	3.49%	-11.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.518M	$7.887M	$4.462M
YoY Change	68.49%	73.88%	-5.06%
Goodwill	$2.603M	$265.0K
YoY Change
Intangibles	$3.379M	$2.322M	$48.00K
YoY Change	6939.58%	3973.68%
Long-Term Investments			$400.0K
YoY Change			-60.0%
Other Assets	$83.00K	$102.0K	$150.0K
YoY Change	-44.67%	-3.77%	-97.12%
Total Long-Term Assets	$16.19M	$16.61M	$10.21M
YoY Change	58.62%	58.13%	-7.2%
TOTAL ASSETS
Total Short-Term Assets	$65.50M	$43.33M	$42.91M
Total Long-Term Assets	$16.19M	$16.61M	$10.21M
Total Assets	$81.69M	$59.94M	$53.12M
YoY Change	53.8%	14.45%	-10.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.30M	$4.500M	$7.800M
YoY Change	32.05%	12.5%	25.81%
Accrued Expenses	$200.0K	$400.0K	$400.0K
YoY Change	-50.0%	33.33%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$15.00M	$264.0K	$300.0K
YoY Change	4900.0%	-8.01%	-98.34%
Total Short-Term Liabilities	$25.48M	$11.21M	$8.543M
YoY Change	198.27%	-42.82%	-65.45%
LONG-TERM LIABILITIES
Long-Term Debt	$4.377M	$4.389M	$458.0K
YoY Change	855.68%	-6.04%	-90.35%
Other Long-Term Liabilities	$1.502M	$333.0K
YoY Change
Total Long-Term Liabilities	$5.879M	$4.722M	$458.0K
YoY Change	1183.62%	1.09%	-90.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.48M	$11.21M	$8.543M
Total Long-Term Liabilities	$5.879M	$4.722M	$458.0K
Total Liabilities	$31.36M	$15.94M	$9.001M
YoY Change	248.41%	-34.37%	-70.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.04M	-$17.83M	-$16.75M
YoY Change	-28.1%	4.21%
Common Stock	$327.0K	$323.0K	$320.0K
YoY Change	2.19%	28.69%	27.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$50.33M	$44.00M	$44.11M
YoY Change
Total Liabilities & Shareholders Equity	$81.69M	$59.94M	$53.12M
YoY Change	53.8%	14.45%	-10.88%

Cashflow Statement

Concept	2015 Q3	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	$1.082M	-$1.080M	-$108.0K
YoY Change	-1101.85%	-29.41%	-98.82%
Depreciation, Depletion And Amortization	$540.0K	$350.0K	$220.0K
YoY Change	145.45%	66.67%	4.76%
Cash From Operating Activities	-$5.000M	-$2.950M	-$390.0K
YoY Change	1182.05%	321.43%	-104.81%
INVESTING ACTIVITIES
Capital Expenditures	-$100.0K	-$190.0K	-$260.0K
YoY Change	-61.54%		420.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$7.370M	$0.00
YoY Change		-3609.52%	-100.0%
Cash From Investing Activities	-$110.0K	-$7.550M	-$260.0K
YoY Change	-57.69%	-3695.24%	271.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.660M	10.27M	-80.00K
YoY Change	-5925.0%	-468.1%	-98.76%
NET CHANGE
Cash From Operating Activities	-5.000M	-2.950M	-390.0K
Cash From Investing Activities	-110.0K	-7.550M	-260.0K
Cash From Financing Activities	4.660M	10.27M	-80.00K
Net Change In Cash	-450.0K	-230.0K	-730.0K
YoY Change	-38.36%	-92.99%	-146.5%
FREE CASH FLOW
Cash From Operating Activities	-$5.000M	-$2.950M	-$390.0K
Capital Expenditures	-$100.0K	-$190.0K	-$260.0K
Free Cash Flow	-$4.900M	-$2.760M	-$130.0K
YoY Change	3669.23%	294.29%	-101.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7518000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	397000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	43328000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7887000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	83000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2609000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	6031000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	2603000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	265000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3379000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2322000	USD
CY2015Q3	us-gaap	Assets Assets	81691000	USD
CY2014Q4	us-gaap	Assets Assets	59935000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	241000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	384000	USD
CY2015Q3	us-gaap	Debt Current DebtCurrent	14983000	USD
CY2014Q4	us-gaap	Debt Current DebtCurrent	6320000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1040000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5484000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1011000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	65499000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	102000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	25481000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1894000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	397000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	663000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1524000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	503000	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17298000	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13801000	USD
	us-gaap	Gross Profit GrossProfit	17121000	USD
	us-gaap	Gross Profit GrossProfit	5500000	USD
CY2015Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	958000	USD
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	630000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2972000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9614000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3968000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	48964000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	37017000	USD
CY2015Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10257000	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4510000	USD
CY2015Q3	us-gaap	Revenues Revenues	21682000	USD
CY2014Q3	us-gaap	Revenues Revenues	15296000	USD
	us-gaap	Revenues Revenues	72422000	USD
	us-gaap	Revenues Revenues	47755000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2609000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	1622000	USD
	us-gaap	Operating Expenses OperatingExpenses	7188000	USD
	us-gaap	Operating Expenses OperatingExpenses	4503000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1902000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-127000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	9933000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	157000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	99000	USD
	us-gaap	Interest Expense InterestExpense	600000	USD
	us-gaap	Interest Expense InterestExpense	494000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9333000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-118000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3547000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	1082000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-108000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5786000	USD
	us-gaap	Net Income Loss NetIncomeLoss	360000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32639429	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32487230	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28179853	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33856045	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32031426	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34071982	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	997000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-226000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42255000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	333000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4377000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4389000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	31360000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	15936000	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62047000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61505000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12043000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17829000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	50331000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	43999000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81691000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59935000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55301000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1502000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	4384000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	1495000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11214000	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32031426	shares
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	992000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4216000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	2482000	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1622000	USD
	us-gaap	Interest Paid InterestPaid	531000	USD
	us-gaap	Interest Paid InterestPaid	413000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1745000	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-3669000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3006000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1196343	shares
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3676661	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	75000	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29839975	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	626000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	48000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	48000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	162000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	29000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	69000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	81000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3422000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	193000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5694000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5378000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10497000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6314000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4521000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4355000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4104000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4027000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5499000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4654000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2424000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	647000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	534000	USD
	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	0	USD
	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	63000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3078000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-481000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	384000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15639000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	8580000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-15080000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	243000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4228000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8682000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	105000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	504000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	669000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1173000	USD
	hdsn	Noncash Or Par Tnoncash Deferred Acquisition Consideration NoncashOrParTnoncashDeferredAcquisitionConsideration	2669000	USD
	hdsn	Noncash Or Par Tnoncash Deferred Acquisition Consideration NoncashOrParTnoncashDeferredAcquisitionConsideration	0	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2709000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	292000	USD
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	331000	USD
	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	0	USD
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1991-01-11
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.34	pure
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.26	pure
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	6428000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	80843	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	162000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	6000000	shares
CY2015Q3	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	4306523	shares
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	51000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1043000	USD
	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue	9000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0169	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.59	pure
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	793000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	69032000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	44011000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3390000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3744000	USD
CY2015Q1	hdsn	Number Of Employees NumberOfEmployees	3	pure
CY2015Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1606000	USD
CY2015Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	1500000	USD
CY2015Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	2338000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P6Y
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40000000	USD
CY2013Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	44000	USD
CY2015Q3	us-gaap	Line Of Credit LineOfCredit	18600000	USD
CY2015Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	14200000	USD
CY2015Q3	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0375	pure
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	HUDSON TECHNOLOGIES INC /NY
	dei	Entity Central Index Key EntityCentralIndexKey	0000925528
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	HDSN
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32686196	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Estimates and Risks</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect reported amounts of certain assets and liabilities, the disclosure of contingent assets and liabilities, and the results of operations during the reporting period. Actual results could differ from these estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Several of the Company's accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. As a result of litigation, the federal regulations implementing the January 2010 phase down schedule were vacated, and in April 2013, the Environmental Protection Agency (“EPA”) published a final rule providing for the production or importation of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 63</font> million and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">51</font> million pounds of HCFC-22 in 2013 and 2014, respectively. On October 16, 2014, the Administrator of the EPA signed a final rule providing further reductions in the production and consumption allowances for virgin HCFC refrigerants for the years 2015 through 2019 (the “Final Rule”). In the Final Rule, the EPA established a linear draw down for the production or importation of virgin HCFC-22 that starts at approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Credit Risk</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">For the nine month period ended September 30, 2015, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">two customers each accounted for 10% or more of the Company’s revenues</font> and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 34</font>% of the Company’s revenues. At September 30, 2015, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,100,000</font> in outstanding receivables from these customers.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">For the nine month period ended September 30, 2014, two customers each accounted for 10% or more of the Company’s revenues and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 26</font>% of the Company’s revenues. At September 30, 2014, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,004,000</font> in outstanding receivables from these customers.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have a material adverse effect on the Company's operating results and financial position.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	two customers each accounted for 10% or more of the Companys revenues
	hdsn	Production And Importation Permission Description ProductionAndImportationPermissionDescription	22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020.
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	327000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	323000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10000	USD
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32676196	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32676196	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32312276	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32312276	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3026000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P2Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9827	shares
CY2015Q1	hdsn	Business Acquisition Purchase Price Allocation Description BusinessAcquisitionPurchasePriceAllocationDescription	The purchase price for this acquisition was $2,424,000 cash paid at closing and the assumption of a liability of $20,000, plus a maximum of an additional $3,000,000 earn out, of which approximately $331,000 has been paid out as of September 30, 2015. The remaining balance of $2,669,000 is accrued on the consolidated balance sheet as of September 30, 2015
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9827	shares
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	two customers each accounted for 10% or more of the Company’s revenues
	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Approximately $6,700,000 of the Company’s $7,600,000 of NOLs are subject to annual limitations of $1,300,000
CY2013	hdsn	Production Or Importation Of Hcfc ProductionOrImportationOfHcfc	63000000	lb
CY2014	hdsn	Production Or Importation Of Hcfc ProductionOrImportationOfHcfc	51000000	lb
	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	Interest charges with respect to loans are computed on the actual principal amount of loans outstanding during the month at a rate per annum equal to (A) with respect to Domestic Rate Loans (as defined in the PNC Facility), the sum of the Alternate Base Rate (as defined in the PNC Facility) plus one half of one percent (.50%) and (B) with respect to Eurodollar Rate Loans, the sum of the Eurodollar Rate plus two and one quarter of one percent( 2.25%).

Files In Submission

Name	View Source	Status
0001144204-15-064117-index-headers.html	Edgar Link	pending
0001144204-15-064117-index.html	Edgar Link	pending
0001144204-15-064117.txt	Edgar Link	pending
0001144204-15-064117-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hdsn-20150930.xml	Edgar Link	completed
hdsn-20150930.xsd	Edgar Link	pending
hdsn-20150930_cal.xml	Edgar Link	unprocessable
hdsn-20150930_def.xml	Edgar Link	unprocessable
hdsn-20150930_lab.xml	Edgar Link	unprocessable
hdsn-20150930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v423337_10q.htm	Edgar Link	pending
v423337_ex3-1.htm	Edgar Link	pending
v423337_ex31-1.htm	Edgar Link	pending
v423337_ex31-2.htm	Edgar Link	pending
v423337_ex32-1.htm	Edgar Link	pending
v423337_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2015 Q3 Form 10-Q Financial Statement

#000114420415064117 Filed on November 10, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2015 Q3 Form 10-Q Financial Statement

#000114420415064117 Filed on November 10, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn